Gut-adipose tissue axis in hepatic fat accumulation in humans




Munukka Eveliina, Pekkala Satu, Wiklund Petri, Rasool Omid, Borra Ronald, Kong Lingjia, Ojanen Xiaowei, Cheng Shu Mei, Roos Christophe, Tuomela Soile, Alen Markku, Lahesmaa Riitta, Cheng Sulin

PublisherElsevier

2014

Journal of Hepatology

J Hepatol

61

1

132

138

7

0168-8278

DOIhttps://doi.org/10.1016/j.jhep.2014.02.020





Background & Aims

Recent evidence suggests that in animals gut microbiota composition (GMC) affects the onset and progression of hepatic fat accumulation. The aim of this study was to investigate in humans whether subjects with high hepatic fat content (HHFC) differ in their GMC from those with low hepatic fat content (LHFC), and whether these differences are associated with body composition, biomarkers and abdominal adipose tissue inflammation.



Methods

Hepatic fat content (HFC) was measured using proton magnetic resonance spectroscopy (1H MRS). Fecal GMC was profiled by 16S rRNA fluorescence in situ hybridization and flow cytometry. Adipose tissue gene expression was analyzed using Affymetrix microarrays and quantitative PCR.



Results

The HHFC group had unfavorable GMC described by lower amount of Faecalibacterium prausnitzii (FPrau) (p <0.05) and relatively higher Enterobacteria than the LHFC group. Metabolically dysbiotic GMC associated with HOMA-IR and triglycerides (p <0.05 for both). Several inflammation-related adipose tissue genes were differentially expressed and correlated with HFC (p <0.05). In addition, the expression of certain genes correlated with GMC dysbiosis, i.e., low FPrau-to-Bacteroides ratio.



Conclusions

HHFC subjects differ unfavorably in their GMC from LHFC subjects. Adipose tissue inflammation may be an important link between GMC, metabolic disturbances, and hepatic fat accumulation.




 



Last updated on 2024-26-11 at 22:23